The Vanderbilt Emergency Medicine Research Training Program (VEMRT)
范德比尔特急诊医学研究培训计划 (VEMRT)
基本信息
- 批准号:8889712
- 负责人:
- 金额:$ 65.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2016-04-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAptitudeAreaArrhythmiaAsthmaBasic ScienceCardiopulmonaryCaringClinical InvestigatorClinical ResearchDevelopmentDiagnosisDiseaseEmergency CareEmergency MedicineEmergency SituationHeart failureHuman GenomeKnowledgeLifeMentorsMolecularNCI Scholars ProgramPatientsPharmacogenomicsPhysiciansRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch TrainingResidenciesScientistTimeTrainingTraining ProgramsTranslatingUniversitiesVisionacute coronary syndromebiomedical informaticscareercareer developmentcomparative effectivenessdesignimprovedinjuredinnovationprogramsskills
项目摘要
DESCRIPTION (provided by applicant): Remarkable advances in the diagnosis and management of acute, life-threatening cardiopulmonary and hematologic disorders have occurred in past decades. However, there is growing national concern that expert emergency medicine clinical investigators who can translate new research findings to practice are insufficient in number. It has never been more important to create and maintain a cadre of emergency care physician- scientists, given the unprecedented developments at the cellular and molecular level, including knowledge of the human genome. Innovation in selection, training and career development of new investigators is greatly needed. Vanderbilt University has an extremely successful history in developing well trained researchers who have the vision and skills to embark on successful careers in clinical research. A new career development program, the "Vanderbilt Emergency Medicine Scholars Program" will focus on training and mentoring physician-scientists in all aspects of research necessary to prepare them for the unique challenges associated with translating basic science into care improvements for acutely ill or injured patients. Although clinically oriented, the program will also highlight the importance of collaborating with basic researchers in hypothesizing and designing clinical research. Two new clinician-scientists who have completed residency (or clinicians with PhDs or equivalent training) and who show exceptional aptitude for successfully pursuing an academic research career will be accepted per year. A total of six Scholars will participate at any one time. The program will concentrate on developing expertise in four focus areas: 1) acute lung injury, 2) asthma, 3) arrhythmias, and 4) acute coronary syndromes and heart failure. These are areas of national recognition and presence for Vanderbilt, and will be bolstered by rich institutional strengths in biomedical informatics, comparative effectiveness, pharmacogenomics, our existing emergency medicine research infrastructure, and continual attraction of a deep, diverse candidate pool. The Program Directors, Douglas B. Sawyer, MD and Alan B. Storrow, MD, have assembled a team of experts in each focus area who are currently engaged in successful academic research and who have devoted their careers to training and mentoring new investigators; both early (Mentors-in-Training) and more senior investigators (Primary Research Mentors) will combine with experts in career development (Academic Mentors) to support Scholars on their paths to independence and contribution to improved diagnosis and management of emergencies.
描述(由申请人提供):在过去的几十年里,在急性、危及生命的心肺和血液疾病的诊断和治疗方面取得了显著的进展。然而,越来越多的人担心,能够将新研究成果转化为实践的急诊医学临床研究专家数量不足。考虑到细胞和分子水平上前所未有的发展,包括人类基因组的知识,建立和维持一支急诊医生-科学家的骨干队伍从未像现在这样重要。在新研究者的选择、培训和职业发展方面进行创新是非常必要的。范德比尔特大学在培养训练有素的研究人员方面有着极其成功的历史,这些研究人员有远见和技能,可以在临床研究领域取得成功。一项新的职业发展计划,“范德比尔特急救医学学者计划”将重点培训和指导医生科学家在必要的研究的各个方面,为他们准备将基础科学转化为急性疾病或受伤患者的护理改进的独特挑战。虽然以临床为导向,但该计划也将强调与基础研究人员在假设和设计临床研究方面合作的重要性。每年将接受两名新的临床医生-科学家,他们已完成住院医师(或具有博士学位或同等培训的临床医生),并表现出成功追求学术研究事业的特殊才能。每次参赛人数为6人。该项目将集中发展四个重点领域的专业知识:1)急性肺损伤,2)哮喘,3)心律失常,4)急性冠状动脉综合征和心力衰竭。这些都是范德比尔特在全国范围内得到认可和存在的领域,并将得到生物医学信息学、比较有效性、药物基因组学、我们现有的急诊医学研究基础设施以及不断吸引深入、多样化的候选人池等方面的丰富机构优势的支持。项目主管Douglas B. Sawyer医学博士和Alan B. Storrow医学博士在每个重点领域组建了一个专家团队,他们目前从事成功的学术研究,并致力于培训和指导新的研究人员;早期(培训导师)和更高级的研究人员(初级研究导师)将与职业发展专家(学术导师)结合,支持学者走上独立之路,并为改进紧急情况的诊断和管理做出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEAN PATRICK COLLINS其他文献
SEAN PATRICK COLLINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEAN PATRICK COLLINS', 18)}}的其他基金
Improving Diagnostic Accuracy for Acute Heart Failure
提高急性心力衰竭的诊断准确性
- 批准号:
10617357 - 财政年份:2021
- 资助金额:
$ 65.79万 - 项目类别:
Improving Diagnostic Accuracy for Acute Heart Failure
提高急性心力衰竭的诊断准确性
- 批准号:
10405617 - 财政年份:2021
- 资助金额:
$ 65.79万 - 项目类别:
Improving Diagnostic Accuracy for Acute Heart Failure
提高急性心力衰竭的诊断准确性
- 批准号:
10209800 - 财政年份:2021
- 资助金额:
$ 65.79万 - 项目类别:
A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients with Acute Heart Failure
方案利尿疗法与标准护理在急诊室急性心力衰竭患者中的随机试验
- 批准号:
10507806 - 财政年份:2021
- 资助金额:
$ 65.79万 - 项目类别:
The Vanderbilt Emergency Medicine Research Training Program (VEMRT)
范德比尔特急诊医学研究培训计划 (VEMRT)
- 批准号:
9289889 - 财政年份:2011
- 资助金额:
$ 65.79万 - 项目类别:
Treatment Endpoints in Acute Decompensated Heart Failure
急性失代偿性心力衰竭的治疗终点
- 批准号:
7916677 - 财政年份:2008
- 资助金额:
$ 65.79万 - 项目类别:
Treatment Endpoints in Acute Decompensated Heart Failure
急性失代偿性心力衰竭的治疗终点
- 批准号:
8345106 - 财政年份:2008
- 资助金额:
$ 65.79万 - 项目类别:
Treatment Endpoints in Acute Decompensated Heart Failure
急性失代偿性心力衰竭的治疗终点
- 批准号:
7679370 - 财政年份:2008
- 资助金额:
$ 65.79万 - 项目类别:
Treatment Endpoints in Acute Decompensated Heart Failure
急性失代偿性心力衰竭的治疗终点
- 批准号:
8262163 - 财政年份:2008
- 资助金额:
$ 65.79万 - 项目类别:
Treatment Endpoints in Acute Decompensated Heart Failure
急性失代偿性心力衰竭的治疗终点
- 批准号:
7531959 - 财政年份:2008
- 资助金额:
$ 65.79万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 65.79万 - 项目类别:














{{item.name}}会员




